G Biosciences

Executive Summary

G Biosciences is a privately held US biotechnology company established in 2001, headquartered in St. Louis, Missouri. The company specializes in developing and manufacturing research tools, reagents, assays, and kits for the life sciences market, with a primary focus on proteomics. Its product portfolio also spans nucleic acids, molecular biology, bioassays, and cell biology. G Biosciences operates as an ISO-certified, cGMP-compliant contract manufacturer, supplying both academic researchers and industrial clients. While the company has a solid market presence and regulatory compliance, it remains a private entity with limited public financial disclosure, which constrains detailed investment analysis. However, its established reputation and broad product catalog position it as a reliable partner in the life sciences tools space.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Proteomics Assay Kit70% success
• Q4 2026Expansion of Contract Manufacturing Capacity65% success
• TBDStrategic Partnership with Major Pharmaceutical Company50% success